Results 11 to 20 of about 150,246 (305)

Body composition change during neoadjuvant chemotherapy for breast cancer [PDF]

Frontiers in Oncology, 2022
BackgroundSarcopenia is receiving attention in oncology as a predictor of increased chemotherapy toxicities. Research into body composition change during neoadjuvant chemotherapy for breast cancer is both urgently needed and generally lacking. This study
Min Kyeong Jang, Seho Park, Chang Park, Ardith Z. Doorenbos, Ardith Z. Doorenbos, Jieon Go, Sue Kim   +6 more
doaj   +2 more sources

Neoadjuvant chemotherapy in breast cancer

British Journal of Surgery, 2005
Abstract Background Neoadjuvant chemotherapy for breast cancer was originally used in locally advanced inoperable disease in order to achieve surgical resection. It was then extended to operable breast cancer with a view to downstaging tumours to facilitate breast-conserving surgery.
Charfare, H, Limongelli, S, Purushotham, A D   +2 more
openaire   +4 more sources

Clinical outcome and predictive factors for docetaxel and epirubicin neoadjuvant chemotherapy of locally advanced breast cancer [PDF]

The Korean Journal of Internal Medicine, 2020
Background/Aims We evaluated the efficacy of docetaxel and epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer and assessed the predictive factors for response to neoadjuvant chemotherapy and prognostic factors related to relapse ...
Hye Sung Won, Yong Seok Kim, Jeong Soo Kim, Eun Deok Chang, Sae Jung Na, In Yong Whang, Dong Soo Lee   +6 more
doaj   +1 more source

Neoadjuvant therapy in patients with locally advanced colon cancer [PDF]

Waike lilun yu shijian, 2022
It is still unclear about neoadjuvant therapy in patients with locally advanced colon cancer (LACC). This review summarized neoadjuvant chemotherapy, neoadjuvant chemotherapy combined with targeted therapy and combined radio-chemotherapy for the patients
XU Zifeng, ZONG Yaping, LU Aiguo
doaj   +1 more source

Clinicopathological factors affecting the effect of neoadjuvant chemotherapy in patients with gastric cancer

World Journal of Surgical Oncology, 2021
Background Neoadjuvant chemotherapy is an important part of the comprehensive treatment of advanced gastric cancer (GC). The effect of neoadjuvant chemotherapy plays a key role in the prognosis of GC patients.
Lin Jiang, Zhiqiang Ma, Xin Ye, Weiming Kang, Jianchun Yu   +4 more
doaj   +1 more source

The Therapeutic Effectiveness of Neoadjuvant Trastuzumab Plus Chemotherapy for HER2-Positive Breast Cancer Can Be Predicted by Tumor-Infiltrating Lymphocytes and PD-L1 Expression

Frontiers in Oncology, 2022
IntroductionNeoadjuvant trastuzumab plus chemotherapy may affect programmed death-ligand 1 (PD-L1) expression and tumor-infiltrating lymphocytes (TILs) in HER2-positive breast cancer.
Mao Shang, Mao Shang, Yajing Chi, Jianbo Zhang, Jin Chang, Hui Yang, Sha Yin, Qiaorui Tan, Xiaochu Man, Huihui Li   +9 more
doaj   +1 more source

Neoadjuvant PD-1 blockade plus chemotherapy versus chemotherapy alone in locally advanced stage II-III gastric cancer: A single-centre retrospective study

Translational Oncology, 2023
Background: PD-1 blockade has been shown to have promising efficacy and acceptable safety profiles in advanced and metastatic gastric cancer; however, the efficacy and safety of neoadjuvant PD-1 blockade-based immunotherapy plus chemotherapy in locally ...
Xuchen Zhang, Chuantao Zhang, Helei Hou, Yuming Zhang, Peng Jiang, Hai Zhou, Lele Wang, Na Zhou, Xiaochun Zhang   +8 more
doaj   +1 more source

Increasing Neoadjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients [PDF]

, 2020
Nasopharyngeal carcinoma (NPC) has radiosensitive and chemosensitive properties. The lack of radiotherapy devices makes concurrent chemoradiation difficult in Indonesia.
Muhtarum Yusuf, -, Andri Foris, -
core   +1 more source

Comparison of neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable stage III non-small cell lung cancer: a real-world cohort study

Frontiers in Immunology, 2023
BackgroundWe compared the real-world efficacy and safety of neoadjuvant chemoimmunotherapy to chemotherapy alone in patients with stage III non-small-cell lung cancer (NSCLC).Participants and methodsA total of 59 consecutive patients were finally ...
Sihao Zhou, Yi Liu, Kejun Liu, Junkai Zhang, Hanlin Liang, Yingmeng Wu, Hongyu Ye, Yi Liang, Jingjing Zhang, Weizhao Huang   +9 more
doaj   +1 more source

Neoadjuvant Chemotherapy In Stadium Ib3, Iia2 And Iib Cervical Cancer

Andalas Obstetrics and Gynecology Journal, 2023
Aim: This study aimed to describe Paclitaxel-Carboplatin chemotherapy as neoadjuvant chemotherapy in stage IB3, IIA2 and IIB cervical cancer.   Materials and Methods: The review was conducted by collecting journals from previous studies discussing ...
I Gde Sastra GdeSastra Winata
doaj   +1 more source